FacultyFaculty/Author Profile
Daniel L. Reisner

Daniel L. Reisner

Arnold & Porter Kaye Scholer LLP

New York City, NY, USA


Daniel Reisner focuses on patent and trade secret litigation, intellectual property licensing, and general complex commercial disputes. His intellectual property experience includes biotechnology, pharmaceuticals, ANDA litigations, medical devices, telecommunications, computers, plastic injection molding manufacture, and aerospace systems.

Mr. Reisner has worked on numerous trials and has broad experience in all phases of litigation. Examples of matters on which Mr. Reisner has worked include representation of Pfizer Inc. in a patent infringement suit brought by the University of Rochester involving Celebrex®, a multibillion-dollar drug for the treatment of arthritis. The case resulted in a victory for Pfizer with a decision by the Federal Circuit upholding the district court's decision invalidating the patent-in-suit on a motion for summary judgment. In a subsequent suit against a generic, Mr. Reisner represented Pfizer in obtaining a victory at trial and affirmance on appeal.

Mr. Reisner also represents clients in telecommunications- and computer-related patent disputes. The technologies involved aspects of broadband data and video transmission, coaxial cable and optical data transmission, headends, data centers, computer networking, satellite communication, NTSC, ATSC, MPEG and DOCSIS standards, videotex, handheld computing, memory, peripherals, and microprocessors.

Daniel L. Reisner is associated with the following items:
Course Handbooks  Course Handbooks Developments in Pharmaceutical and Biotech Patent Law 2016
CHB Chapters  CHB Chapters Willfulness: A Return to the Bad Old Days (2016) - Developments in Pharmaceutical and Biotech Patent Law 2016, Monday, December 12, 2016
Excerpt from Ch. 5: Patentability, Practising Law Institute, Pharmaceutical and Biotech Patent Law § 5:4.5 [C] (November 2016) - Developments in Pharmaceutical and Biotech Patent Law 2017, Wednesday, November 01, 2017
Excerpt from Ch. 7: Types of Biological and Pharmaceutical Patents, Practising Law Institute, Pharmaceutical and Biotech Patent Law § 7:7 (November 2016) - Developments in Pharmaceutical and Biotech Patent Law 2017, Wednesday, November 01, 2017
Web Segment  Web Segment Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges - Developments in Pharmaceutical and Biotech Patent Law 2017, Thursday, November 02, 2017
MP3 Audio  MP3 Audio Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges - Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges, Thursday, November 02, 2017
Transcripts  Transcripts Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges - Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges, Thursday, November 02, 2017
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges - Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges, Thursday, November 02, 2017
On-Demand Web Programs  On-Demand Web Programs Developments in Pharmaceutical and Biotech Patent Law 2017, Monday, November 06, 2017, New York, NY
Treatise Chapters  Treatise Chapters Patentability - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
An Overview of Research & Development, Product Launch, and Patent Enforcement - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Biological Deposits - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Inventorship - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Utility and Patentable Subject Matter Requirements - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Types of Biological and Pharmaceutical Patents - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Live Seminar  Live Seminar Developments in Pharmaceutical and Biotech Patent Law 2018, Wednesday, October 31, 2018, New York, NY
Live Webcast  Live Webcast Developments in Pharmaceutical and Biotech Patent Law 2018, Wednesday, October 31, 2018, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.